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Disability from movement disorders is often 
seen as par for the course in the ageing 
process. It is the price paid by those who 
are lucky enough to grow old. There are, 
however, also young patients who develop 
Parkinson’s disease (PD) and dystonia and 
have to discontinue their profession owing to 
a severely disabling tremor or task-specific 
dystonia, such as writer’s cramp or musician’s 
dystonia. In this group of patients, especially, 
awareness about surgical options to alleviate 
disability caused by their movement disorder 
is of the utmost importance.
Surgical procedures performed for move-
ment disorders are classically divided into 
two categories (Table 1).
Pathophysiology of 
movement disorders
To understand the principles behind the sur-
gical management of movement disorders, 
we first need to review the basic physiology 
of movement. This is a complex topic and a 
detailed discussion is beyond the scope of 
this article, but a brief overview is given. 
Human movement is the end result of 
a complex, orchestrated and masterfully 
executed interaction of sensory feedback, 
modulation and action. Human movement 
is planned in the frontal lobes and is strongly 
linked to the need for reward. At the most 
primitive level, one performs an action to 
achieve an award. 
Four cerebral areas are involved in human 
movement:
• primary motor cortex: e.g. sending the 
message via the corticospinal tracts to a 
limb
• secondary motor cortex (supplementary 
motor area): planning of movement
• prefrontal cortex: adding emotional influ-
ence to our move ments
• cingulate gyrus.
There are also subcortical structures involved 
in movement:
• basal ganglia: thalamus, globus pallidus 
and subthalamic nucleus (STN)
• cerebellum: ‘fine tuning’ of all movement 
takes place here
• white matter tracts: corticospinal tract, 
reticulospinal tracts and  afferent tracts, 
e.g. spinothalamic.
The basal ganglia and cerebellum form part of 
a complex circuit controlled by positive and 
negative feedback loops.[1] There is a network 
of connectivity between the thalamic nulei, 
cerebellum,  STN and globus pallidus, which 
modifies and refines our actions. Dopamine 
plays an important role as the main neuro-
transmitter substance in this network. The 
physiological effect of lesioning or deep brain 
stimulation (DBS) on these nuclei is still 
unknown, but the most likely explanation is 
that the damping effect of PD is alleviated by 
high-frequency stimulation of the STN, while 
the inverse happens in dystonia, where stimu-
lation of the globus pallidus interna (GPi) 
dampens the abnormal tone and movements. 
Much research is being done worldwide, with 
some units using viral tractography mapping 
studies that show the interconnectedness of 
all the abovementioned nuclei in controlling 
movements.
Parkinson’s disease
PD occurs more commonly in patients of 
55 - 65 years of age and it is estimated that 
up to 2% of people >60 years old will develop 
the condition.[2] PD is characterised by the 
clinical triad of bradykinesia, resting tremor 
and postural instability.[3] Some of the asso-
ciated features are bradymemia (slowness of 
thoughts), bradyphrenia and gait abnormali-
ties, such as festination (shuffling gait).[3] 
Also note that PD has associated non-motor 
symptoms. These are mostly resistant to all 
surgical interventions and include cogni-
tive impairment, mood disturbances, sleep 
disturbances and even autonomic disorders.[4] 
These non-motor symptoms often cause most 
dysfunction in previously high-performing 
individuals with PD. Care and support 
should therefore not be solely fixated on the 
movements or tremors, but a holistic multi-
disciplinary approach is essential.
DBS of the STN was recommended for 
patients with PD by the American Academy 
of Neurologists in 2006.[5] The GPi is also a 
therapeutic target, but is best reserved for 
patients with PD where rigidity is the main 
feature.[5] Ideal candidates for DBS are those 
with pre-operative good motor response to 
levodopa therapy during their ‘on period’.[6] 
DBS has been shown to reduce the ‘off time’ 
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Table 1. Possible surgical procedures for treating movement disorders
Lesioning procedures Neuromodulation
Stereotactic lesioning of basal ganglia and/or thalamic targets Deep brain stimulation
Selective peripheral denervation of specific muscles Intrathecal baclofen therapy
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in patients and the need for medication, and 
improve dyskinesia and  motor function.[4] 
The ideal candidates for DBS are summarised 
in Table 2. The reason for waiting for 5 - 6 years 
of symptomatic PD before considering DBS, is 
to allow ample time for excluding differential 
diagnoses such as other neurodegenerative 
diseases; also, most patients develop motor 
fluctuations and dyskinesias only after this 
time period.[7] There is, however, good evi-
dence to support the early use of DBS in 
patients with motor fluctuations caused by 
PD.[8] Patients experience good resolution of 
these effects and therefore must be referred 
for surgical treatment options early in the 
disease. It is important to note that there is no 
benefit with regard to the non-motor effects, 
and there is some concern related to suicide 
risk, which is slightly higher after surgery. 
This may be due to the motor disability being 
relieved, but not the mood disturbances.[9]
Dystonia
Dystonia forms part of the complex of disor-
ders that present with abnormal movements. 
It is classified into focal and generalised dys-
tonia and further into primary and second-
ary causes. The mainstay of focal dystonia 
is local intramuscular injection with botu-
linum toxin, which causes local paralysis of 
the injected muscle fibres.[10] This can allow 
the patient with focal types of dystonia, such 
as musician’s cramp or cervical torticollis, to 
have normalised movements of their hands 
or neck, depending on the pathology and 
the selected injection sites. Botulinum toxin 
is effective for 5 - 6 months, and usually 
requires repeated injections to control the 
disability. In long-standing cases of focal 
dystonia, such as spasmodic cervical torti-
collis, selective peripheral denervation of the 
sternocleidomastoid muscle, trape zius and 
splenius capitis muscles in the neck can lead 
to significant improvement in the torticollis 
(the Bertrand procedure).
In focal dystonia of the hand some authors 
report very good long-lasting effects with 
contralateral lesioning of the ventral oralis 
anterior nucleus of the thalamus.[11] Taira, from 
Japan,[11] is renowned for having the patient 
awake during the procedure, with his/her 
musical instrument in the theatre, and asks the 
patient to perform a musical piece that would 
elicit their dystonia, while he is performing the 
surgical procedure. By doing this he confirms 
the therapeutic effect and avoids any damage to 
the surrounding internal capsule. Stereotactic 
placement of a DBS electrode in these thalamic 
nuclei, or in the GPi, has a similar effect, 
with the added benefit of removal if there are 
any side-effects and the ability to modify the 
stimulation parameters.
Generalised dystonia of genetic cause (spe-
cifically DYT1 abnormality) is the most 
responsive to DBS. Patients with DYT1 dys-
tonia do extremely well after DBS; conse-
quently, it is currently the first-line therapy.
DBS is expensive, but if the cost v. benefit 
analysis is taken into account there is 
significant functional gain for the patient, 
with long-term financial savings with regard 
to hospitalisation and chronic medication 
for funders. There is also major functional 
improvement and freedom of movement with 
the surgical management of dystonia patients.
Essential tremor
Essential tremor is one of the most common 
movement disorders and affects up to 5% 
of the general population.[12] It may affect 
people from all age groups (most com-
monly the elderly) and has a strong familial 
predilection, with an autosomal-dominant 
inheritance pattern.[12] Essential tremor is 
most often of a postural nature and is absent 
at rest. There is a clear exaggeration of this 
tremor with anxiety and stress, relieved by 
alcohol use.[13] Medical management forms 
the mainstay of treatment (beta-blockers, 
gabapentin and other anticonvulsants).[13] 
Once functional ability and quality of life 
are severely impaired by the tremor and it is 
refractory to medical treatment, DBS of the 
ventral intermediate nucleus of the thalamus 
is an option. Lesioning of the same nucleus 
(thalamotomy) may also be considered, with the 
drawback that the procedure is not reversible 
and may be associated with permanent 
neurological deficits after surgery. Up to 90% 
of patients experience a significant reduction in 
the number of tremors in their upper limbs and 
in the severity of the tremors.[13] 
All patients who are candidates for DBS or 
lesioning procedures to treat their movement 
disorder need to undergo some basic blood 
tests, including a coagulation profile. This 
will reduce the risk of potentially catastro-
phic haemorrhagic complications. Generally, 
patients undergo brain imaging, magnetic 
resonance imaging (MRI) being the most 
useful. This is used to merge the stereotactic 
imaging and to exclude cerebral lesions and 
severe cerebral atrophy, which may be contra-
indications to DBS. Imaging also excludes dif-
ferential diagnoses, such Wilson’s disease – a 
dystonic condition treatable with medication 
rather than surgery.
Surgical workflow
The procedure is performed in one of two ways 
by most centres. Two different techniques are 
used to confirm the placement of the electrode 
in the chosen target. Fig. 1 summarises the 
procedures. The most common technique uses 
micro-electrode recording (MER) to confirm 
placement of the electrode. With this tech-
nique, a very thin electrode monitors the elec-
trical activity at an individual neuronal level 
as it is passed through the brain parenchyma. 
The STN and GPi have characteristic electri-
cal waveforms that are readily recog nised by 
experienced neurosurgeons and neurophysi-
ologists. Accuracy is therefore confirmed on 
a physiological level and the best electrode 
position is chosen during the surgical pro-
cedure. The same electrode can be used for 
stimulation, thereby checking for side-effects 
and unplanned effects on nearby structures, 
such as the optic tract or the internal cap-
sule. Repositioning is then possible, during 
which the patient needs to be awake. Fig. 2 
is an intraoperative image of this procedure. 
It may be difficult to perform in the elderly 
and younger children with dystonia, where the 
abnormal movements are so violent that the 
patient cannot be kept still in the head frame. 
Another approach, and the one I prefer, is to 
perform the entire procedure under general 
anaesthesia. The patient has the stereotactic 
frame applied, a stereotactic MRI brain scan 
is performed, and the target planning is done 
while the patient is anaesthetised. Once the 
planning has been done, the frame is applied 
over the frame base (Fig. 3) and the procedure 
is performed. Two burr holes are made behind 
the hairline and the electrodes are placed 
directly on the selected target. After placement 
of both electrodes a stereotactic MRI scan is 
Table 2. Ideal PD patient for DBS
Adequate brain imaging that excludes alternative diagnosis
No cognitive impairment and motivated patient and family
Realistic expectations regarding the potential outcome of DBS
Duration of PD >5 years
Proof of dopamine responsiveness (at least 30% improvement in motor score with dopamine)
Problematic dyskinesia and motor fluctuations despite optimal medical therapy
Disabling medication-resistant tremor
Good medical health
No atypical parkinsonism
≤80 years of age 
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performed again and imaging verification is 
done to confirm the position of the electrode 
in the chosen target (Fig. 4). If the placement 
is accepted, the implantable pulse generator 
(IPG) is inserted in theatre; if not, the electrode 
is first repositioned and then the procedure is 
completed. Frame-based stereotaxis is still the 
gold standard worldwide – the patient is fitted 
with a stereotactic frame that is bolted to the 
head – but there are some units that perform 
frameless stereotactic techniques. 
The IPG is implanted in a subcutaneous 
pocket that is usually created on the left side 
of the chest wall. In very cachectic patients 
the IPG can be implanted in the submuscular 
plane to prevent skin breakdown over the 
device. The two electrodes are tunnelled 
under the skin to connect the implanted 
electrodes to the IPG – similar to a ventri-
culoperitoneal shunt placement.
The day after surgery the IPG is activated 
and a stepwise approach is used to test for 
side-effects and beneficial effects at a range of 
settings. The results of this initial screening 
procedure are used by the team to decide on the 
settings to be used when treating the patient.
Stereotactic lesioning techniques use the 
same workflow as described above, the only 
differences being that patients should not be 
operated on under anaesthesia and a radio-
frequency electrode is placed stereotactically 
to the target in the basal ganglia. Once the 
target is reached, a stimulation pulse is 
used to check for side-effects and confirm 
the therapeutic effect. If there is no risk of 
damaging vital structures, such as the inter-
nal capsule, then a radiofrequency pulse is 
used to create a thermic lesion in the target 
nucleus. This leads to permanent disease 
modification by interrupting the intricate 
feedback mecha nisms that have been dis-
cussed above. 
Follow-up
Once the DBS procedure has been per-
formed, follow-up of patients is the same as 
in those who do not qualify for DBS as treat-
ment of their movement disorder. Patients 
tend to improve if they are kept on low doses 
of their medication, even if symptoms are 
well controlled without medication. In PD, 
for example, it is important to remember 
that DBS does not treat the non-motor 
effects of the disease, and the psychological 
and autonomic components are controlled 
by medication as before. However, the ben-
efit is that dosages can be lowered to levels 
that cause fewer side-effects. 
Two types of IPGs (pacemakers) are used: 
rechargeable and non-rechargeable. The 
advantage of the former is that it only needs 
replacement every 9 - 15 years, depending 
on the manufacturer’s specifications and the 
specific stimulation settings used (higher 
voltages at longer pulse width put more 
strain on the battery than inverse settings). 
The non-rechargeable implant will require 
replacement every 3 - 5 years, again depend-
ing on the settings used and the condition 
treated. Patient factors mostly determine 
which of the two types are used. Dependable 
caregivers or patients with a reliable elec-
tricity supply in their home will easily cope 
with the required once-weekly recharging 
session that is done with a magnetic recharg-
ing device that is placed, and kept, over the 
MER veried Imaging veried 
Awake patient
Stereotactic  frame applied
Stereotactic CT brain performed
Merging of CT to
pre-operative MRI
Stereotactic guidance frame
applied in theatre
DBS electrodes placed
with MER guidance
Most suitable
electrode and
trajectory chosen
IPG implanted and
connector leads tunnelled
Duration: 5 - 8 hours
IPG implanted and
connector leads tunnelled
Duration: 2.5 - 3.5 hours
General anaesthesia
Stereotactic  frame applied
Stereotactic MRI performed
No merging necessary
Stereotactic guidance frame
applied in theatre
DBS electrodes placed
to co-ordinates
Stereotactic MRI done
to conrm placement
Electrode position
changed if not on
target
Fig. 1. Workflow of DBS summary, illustrating the difference between the two techniques
(MER = micro-electrode recording; CT = computed tomography; MRI = magnetic resonance imaging; 
IPG = implantable pulse generator).
Fig. 2. The neurosurgical team placing the DBS 
electrode in a patient who is awake. The stereotactic 
frame is in situ on the patient’s head.
Fig. 3. A patient in the MRI head coil with stereo-
tactic base and fiducial box on the head.
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IPG for ~2 hours, allowing it to recharge. 
In doubtful circumstances or unreliable 
patients, the non-rechargeable option is fail 
safe. Changing of the IPG requires another 
operation, which is associated with higher 
wound infection rates than the primary sur-
gery. This is the major reason for opting for 
a rechargeable device if financial and social 
circumstances allow.
DBS for dystonia differs from that for 
PD and essential tremor in one major 
way: the therapeutic effect of DBS in 
patients with dystonia has a slow onset, 
while in PD and essential tremor the 
effect is immediate. It is important that 
the patient with dystonia and their family 
realise this before the procedure, otherwise 
they are very disappointed and believe that 
the therapy was unsuccessful. Some units 
in Europe inform the patient that it will 
take months for the DBS to start working 
(personal experience), but in general there 
is at least some therapeutic effect in most 
patients in the first month after initiating 
the stimulation. Most patients experience 
a therapeutic effect within 6 months of 
the implantation. I prefer to switch on the 
stimulation device the day after surgery, 
but many surgeons rather wait a few days. 
The rationale behind the waiting period is 
to allow for the slight swelling that is caused 
by the small electrode in the GPi or the STN 
to dissipate so that the effect of stimulation 
can be evaluated in isolation, without the 
lesioning effect playing a role in patient 
improvement.
The effect of the lesioning procedures, 
such as pallidotomy (lesioning in the glo-
bus pallidus) or subthalamic nucleotomy 
(lesioning in the STN), is immediate and 
permanent in most instances. However, even 
in these procedures, the therapeutic effect 
of globus pallidus lesioning will take time 
to manifest. 
Summary 
Surgical management of movement disor-
ders becomes an option only when appropri-
ate medical management has been exhausted 
and the patient’s functioning and quality 
of life are impaired because of the disease. 
The abovementioned three diseases form 
the bulk of movement disorders treated by 
neuro surgeons, but currently targets for DBS 
are increasing by the month. Modern func-
tional neurosurgeons treat pain conditions 
(e.g. cluster headaches) and psychiatric dis-
eases (e.g. anorexia nervosa, major depres-
sive disorder and obsessive compulsive dis-
order) with DBS and lesioning techniques. 
Certain conditions, especially psychiatric 
diseases where the cingulate gyrus is the 
target, lend themselves to lesioning rather 
than DBS. Therefore, lesioning techniques 
that have been performed since the mid-
1900s still play an important role in modern 
neurosurgery. 
It is generally agreed that surgery 
for movement disorders must only be 
performed in specific centres, where 
a multidisciplinary team is involved in 
the pre-operative work-up and the 
postoperative management of the patient. 
Neurosurgeons with special skills and 
aptitude for this type of work are needed; 
therefore, there are not many units in South 
Africa that offer this specialised service. 
Early referral is needed and more needs to 
be done to inform patients, their families 
and the medical fraternity of the surgical 
options for treating movement disorders. 
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Fig. 4. Screenshot of a postoperative MRI scan showing the location of the electrode in the GPi bilaterally 
((C) yellow arrow). The red dot ((C) green arrow) is the planned location that is superimposed on the 
postoperative image. This electrode is in the perfect location in the GPi. (A) Coronal section, (B) sagittal 
section, and (C) axial section of DBS electrodes.
